Mai Capital Management Johnson & Johnson Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

A detailed history of Mai Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Mai Capital Management holds 398,046 shares of JNJ stock, worth $60.9 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

398,046

Previous 482,498 17.5%

Holding current value

$60.9 Million

Previous $70.5 Million 8.53%

% of portfolio

0.64%

Previous 0.71%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$145.48 - $167.38 $12.3 Million - $14.1 Million	-84,452 Reduced 17.5%	398,046 $64.5 Million
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $695,622 - $760,184	-4,818 Reduced 0.99%	482,498 $70.5 Million
Q1 2024 May 08, 2024	BUY	$155.22 - $162.74 $4.94 Million - $5.18 Million	31,800 Added 6.98%	487,316 $77.1 Million
Q4 2023 Feb 09, 2024	BUY	$145.6 - $158.88 $4.98 Million - $5.44 Million	34,233 Added 8.13%	455,516 $71.4 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $589,046 - $659,883	-3,782 Reduced 0.89%	421,283 $65.6 Million
Q2 2023 Aug 02, 2023	BUY	$154.35 - $166.11 $10.4 Million - $11.1 Million	67,087 Added 18.74%	425,065 $70.4 Million
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $3.64 Million - $4.34 Million	-24,091 Reduced 6.31%	357,978 $55.5 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $1.98 Million - $2.22 Million	12,369 Added 3.35%	382,069 $67.5 Million
Q3 2022 Nov 15, 2022	BUY	$161.33 - $179.52 $4.78 Million - $5.31 Million	29,598 Added 8.7%	369,700 $60.4 Million
Q2 2022 Jul 19, 2022	BUY	$168.19 - $186.01 $2.34 Million - $2.59 Million	13,932 Added 4.27%	340,102 $60.4 Million
Q1 2022 May 10, 2022	BUY	$158.14 - $179.59 $2.08 Million - $2.37 Million	13,177 Added 4.21%	326,170 $57.8 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $1.81 Million - $2.01 Million	11,621 Added 3.86%	312,993 $53.5 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $1.58 Million - $1.76 Million	9,812 Added 3.37%	301,372 $48.7 Million
Q2 2021 Jul 19, 2021	SELL	$159.48 - $171.07 $1.83 Million - $1.96 Million	-11,461 Reduced 3.78%	291,560 $48 Million
Q1 2021 May 10, 2021	BUY	$153.07 - $170.48 $5.27 Million - $5.87 Million	34,445 Added 12.83%	303,021 $49.8 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $264,896 - $304,058	-1,932 Reduced 0.71%	268,576 $42.3 Million
Q3 2020 Oct 26, 2020	SELL	$140.38 - $153.83 $429,422 - $470,565	-3,059 Reduced 1.12%	270,508 $40.3 Million
Q2 2020 Jul 27, 2020	BUY	$128.81 - $155.51 $4.23 Million - $5.1 Million	32,821 Added 13.63%	273,567 $38.5 Million
Q1 2020 Apr 16, 2020	BUY	$111.14 - $153.99 $738,969 - $1.02 Million	6,649 Added 2.84%	240,746 $31.6 Million
Q4 2019 Feb 03, 2020	BUY	$127.5 - $146.44 $7.82 Million - $8.98 Million	61,355 Added 35.52%	234,097 $34.1 Million
Q3 2019 Oct 29, 2019	SELL	$126.95 - $142.14 $377,930 - $423,150	-2,977 Reduced 1.69%	172,742 $22.3 Million
Q2 2019 Aug 15, 2019	SELL	$131.15 - $144.24 $854,835 - $940,156	-6,518 Reduced 3.58%	175,719 $24.5 Million
Q1 2019 Apr 29, 2019	BUY	$125.72 - $139.79 $104,976 - $116,724	835 Added 0.46%	182,237 $25.5 Million
Q4 2018 Jan 30, 2019	BUY	$122.84 - $147.84 $932,601 - $1.12 Million	7,592 Added 4.37%	181,402 $23.4 Million
Q3 2018 Oct 12, 2018	BUY	$121.58 - $142.88 $203,160 - $238,752	1,671 Added 0.97%	173,810 $24 Million
Q2 2018 Aug 16, 2018	BUY	$119.4 - $131.76 $454,078 - $501,083	3,803 Added 2.26%	172,139 $20.9 Million
Q1 2018 Apr 17, 2018	BUY	$125.1 - $148.14 $379,803 - $449,753	3,036 Added 1.84%	168,336 $21.6 Million
Q4 2017 Jan 30, 2018	BUY	$131.22 - $143.62 $1.89 Million - $2.07 Million	14,411 Added 9.55%	165,300 $23.1 Million
Q3 2017 Oct 12, 2017	BUY	$129.47 - $135.38 $236,023 - $246,797	1,823 Added 1.22%	150,889 $19.6 Million
Q2 2017 Aug 07, 2017	BUY	N/A	149,066	149,066 $19.7 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Johnson & Johnson Transaction History